Jointly Sponsored by: Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.
About the Program
Program Overview
The Perelman School of Medicine at the University of
Pennsylvania and ViralEd, Inc. are proud to present the "Hepatitis Grand
Rounds" 2019 series. Formerly the "Viral Hepatitis Grand Rounds", this program is modeled
on the ground-breaking CME activity "HIV Grand Rounds," which, in
partnership with the Perelman School of Medicine at the University of
Pennsylvania, is currently in its tenth year. These CME-certified sessions
combine traditional academic grand rounds with the innovation and convenience
of telemedicine. The Hepatitis Grand
Rounds from the Perelman School of Medicine at the University of Pennsylvania
is delivered live via the Internet on two Wednesdays each month at 12:00 pm
Eastern Time and each presentation is available for on-demand viewing immediately
following the live broadcast.
Hepatitis Grand Rounds presentations cover the most important and current
topics in hepatitis, including NASH, HBV and HCV, and are delivered by the top
experts in the field. They are designed to be immediately relevant to
practicing clinicians and many are case-based. The final 10 minutes of each
one-hour educational activity consists of a live question and answer period,
with the presenting faculty member available to answer questions asked by
attendees using the webinar interface. These bi-monthly grand rounds are
intended to provide clinicians with convenient and easily accessible knowledge
and clinical skills they need to provide the best medical care for their hepatitis
patients.
Each session may be broadcast via your Internet connection in your conference
room or auditorium for large groups to view, or individually to your personal
computer at your convenience. Simply register at www.viraled.com/hepatitisgrandrounds for
easy access.
Target Audience
This program has been designed for Family
Medicine, Pediatrics, Neurology, Obstetrics And Gynecology, Psychiatry,
Internal Medicine - Endocrinology, Diabetes And Metabolism, Internal Medicine -
Gastroenterology, Internal Medicine - Infectious Disease, Internal Medicine -
Transplant Hepatology
Commercial Support Acknowledgement
Hepatitis Grand Rounds is supported by educational grants from Gilead Sciences Medical Affairs and Intercept Pharmaceuticals, Inc.
Learning Objectives
After completing this activity, participants should be better able to:
- Demonstrate increased understanding of the epidemiology of and risk factors for
viral hepatitis and NASH
- Increase the rate of testing of viruses and other conditions
associated with hepatitis, such as NASH
- Demonstrate improved knowledge, competence and clinical practice in
terms of the current standards and guidelines for the management of patients
with viral and non-viral hepatitis, including those with NASH
- Demonstrate an improved understanding of the treatment of hepatitis
in patients co-infected with HIV or other viral infections
Course Directors
David E. Kaplan, MD, MSc
Associate Professor of Medicine
Division of Gastroenterology
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
K. Rajender Reddy, MD
Ruimy Family President's Distinguished Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director, Viral Hepatitis Center
Medical Director, Liver Transplantation
Raymond Soccio, MD
Assistant Professor of Medicine
Division of Endocrinology, Diabetes and Metabolism
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Next Session and Participation Information
Presented live at 12:00 PM ET, bi-weekly on Wednesdays and anytime On-Demand
- Delivered via webinar directly to you and/or your clinic
- You, or your clinic's coordinator, will receive a weekly email with topic, speaker and webinar link
- Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer, tablet or smart device
If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.
Live Session Topics and Speakers
March 11, 2020
Real Cases from the University of Pennsylvania (WEBCAST ONLY!)
Raymond Soccio, MD
Click HERE to View On-Demand
April 15, 2020
Liver Function in COVID-19: Case-Based Lessons from the US Epicenter
Elizabeth Verna, MD
Click HERE to View On-Demand
April 29, 2020
Clinical Insights into COVID-19 and the Liver
Oren Fix, MD, MSc, FAASLD
Click HERE to View On-Demand
May 13, 2020
Viral Hepatitis on the Boards (Pre-Recorded)
David Kaplan, MD
Click HERE to View On-Demand
May 27, 2020
Telemedicine for Liver Disease During COVID-19 and Beyond
Marina Serper, MD
Click HERE to View On-Demand
June 10, 2020
Fructose Metabolism and Metabolic Disease
Mark Herman, MD
Click HERE to View On-Demand
June 24, 2020
Hepatitis D: D is for Difficult
Theo Heller, MD
Click HERE to View On-Demand
September 16, 2020
Real Cases from the University of Pennsylvania
David Kaplan, MD and Raymond Soccio, MD
Click HERE to View On-Demand
October 21, 2020
EASL International Liver Congress 2020 Update
Mark Sulkowski, MD
Click HERE to View On-Demand
October 28, 2020
Fatty liver treatments: Lipogenesis as a target
Elizabeth Parks, PhD
Click HERE to View On-Demand
November 11, 2020
Hepatocellular Carcinoma 2020: Updates on Systemic and Multimodal Therapies
Catherine T. Frenette, MD, FAST, AGAF
Click HERE to View On-Demand
November 18, 2020
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Time to Take Action
Kenneth Cusi, MD, FACP, FACE
Click HERE to View On-Demand
December 2, 2020
Viral Hepatitis Update: Liver Meeting 2020 (AASLD)
Mark Sulkowski, MD
Click HERE to View On-Demand
December 9, 2020
Non-alcoholic fatty liver disease: advances in diagnosis & management
Professor Philip Newsome, PhD, FRCPE
Click HERE to View On-Demand
December 16, 2020
Hepatitis B: Update on Novel Antivirals 2020
Adam J. Gehring, PhD
Click HERE to View On-Demand
December 30, 2020
Emerging data on the impact of COVID-19 in chronic liver disease and liver transplantation
A. Sidney Barritt IV, MD, MSCR
Click HERE to View On-Demand
|
Hardware/Software Notice
You will need Internet to participate in this activity.
Accreditation
In support of improving patient care, Penn
Medicine is jointly accredited by the Accreditation Council for Continuing
Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.
Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians
should claim only the credit commensurate with the extent of their
participation in the activity.
Nurses/Pharmacists:
This activity is not approved
for nursing or pharmacy contact hours
PAs: AAPA accepts certificates of participation for educational
activities certified for AMA PRA Category 1 Credit™ from organizations
accredited by ACCME or a recognized state medical society. PAs may receive a
maximum of 1.00 Category 1 credits for completing
this activity.
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at Penn Medicine Office of
Continuing Medical and Interprofessional Education for individuals who are in a
position to control the content of an educational activity to disclose to the
learners all relevant financial relationships that they have with any commercial
interest that provide products or services that may be relevant to the content
of this continuing education activity.
For this purpose, we consider relationships of the person involved to
include financial relationships of a spouse or partner.
The
intent of this policy is to ensure that Penn CME/CE certified activities
promote quality and safety, are effective in improving medical practice, are based
on valid content, and are independent of control from commercial interests and
free of commercial bias. Peer review of all content was conducted for all
faculty presentations whose disclosure information was found to contain
relationships that created a conflict of interest relevant to the topic of
their presentation. In addition, all faculty were instructed to provide
balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of Continuing Medical and Interprofessional Education (CME and
IPCE) have disclosed that they have no relevant financial
relationships with any commercial interests related to the content of this
educational activity. Any peer reviewer with a potential conflict of interest will recuse themselves from the peer review process.
The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
Planning Committee Members:
- Program Co-Chairs: Raymond Soccio, MD
- ViralEd, Inc.: Brian Boyle, MD; Oliver Fultz; Rick Gordon
|
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
K. Rajender Reddy, MD (Program Co-Chair)
- Advisor or Review Panel Member: Gilead; Mallinckrodt, Inc
- Grant/Research Support Recipient: Gilead; Mallinckrodt, Inc; Merck; Intercept; BMS; Exact Sciences; Grifols; Sequana
David Kaplan, MD (Program Co-Chair)
- Grant/Research Support Recipient: Gilead; Bayer Corporation; Glyotest Inc; Elelixis Inc
|
Discussion of Investigational and/or Off-label Use of Commercial Products and Devices
The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
|